Showing results (1121-1130 of 1,172) with videos related to

Sort By:
Pageof 118
Blood|March 27, 2004
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantationAngela Dispenzieri, Morie A Gertz, Robert A Kyle, et al.
Elife|August 11, 2021
Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodiesS Jordan Kerns, Chaitra Belgur, Debora Petropolis, et al.
Blood Advances|September 20, 2023
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent eraSanjal H Desai, Michael A Spinner, Andrew M Evens, et al.
The Science of the Total Environment|March 25, 2023
Offshore decommissioning horizon scan: Research priorities to support decision-making activities for oil and gas infrastructureSarah M Watson, Dianne L McLean, Brian J Balcom, et al.
Blood Cancer Journal|June 24, 2026
Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphomaSanjal H Desai, Susan M Geyer, Levi Pederson, et al.
Nature Medicine|April 17, 2023
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trialZachary D Crees, Michael P Rettig, Reyka G Jayasinghe, et al.
Nature Communications|September 11, 2023
Earthquake-enhanced dissolved carbon cycles in ultra-deep ocean sedimentsMengfan Chu, Rui Bao, Michael Strasser, et al.
American Journal of Hematology|October 23, 2015
Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphomaMatthew J Maurer, Jean-Philippe Jais, Hervé Ghesquières, et al.
Blood|April 21, 2017
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLLWei Ding, Betsy R LaPlant, Timothy G Call, et al.
Frontiers in Immunology|May 4, 2026
Translational strategy to support the first-in-human study of a TCR-like T cell bispecific with an in vitro-based safety approachAngelique Augustin, Blandine Avignon, Christophe Boetsch, et al.
Pageof 118